Active, not recruitingPhase 1NCT05768880

Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors

Studying Diffuse intrinsic pontine glioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Seattle Children's Hospital
Principal Investigator
Rebecca Ronsley, MD
Seattle Children's Hospital
Intervention
SC-CAR4BRAIN(biological)
Enrollment
72 enrolled
Eligibility
1-26 years · All sexes
Timeline
20232043

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05768880 on ClinicalTrials.gov

Other trials for Diffuse intrinsic pontine glioma

Additional recruiting or active studies for the same condition.

See all trials for Diffuse intrinsic pontine glioma

← Back to all trials